The latest Investing Matters Podcast episode with Inclusive Asset Management's Alexandra McGuigan has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 70.60
Bid: 70.60
Ask: 71.60
Change: -2.10 (-2.89%)
Spread: 1.00 (1.416%)
Open: 72.50
High: 73.00
Low: 70.40
Prev. Close: 72.70
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition of Music Catalogue

17 Dec 2018 09:45

RNS Number : 6618K
Hipgnosis Songs Fund Limited
17 December 2018
 

17 December 2018

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

Acquisition of Music Catalogue

The Board of Hipgnosis Songs Fund Limited and its Investment Adviser, The Family (Music) Limited, are pleased to announce that the Company has acquired a music catalogue from Christopher "Tricky" Stewart, an American record producer, songwriter, music publisher and multiple Grammy winner. The Company has acquired a 100% interest in the catalogue including ASCAP (American Society of Composers, Authors and Publishers) income.

The catalogue comprises 121 songs in total, including 8 US Top 10 Pop singles, 3 US Number 1 Pop singles and multiple Grammy winners. It is highly complementary to The-Dream catalogue, which was acquired by the Company on 11 July 2018, as Tricky co-wrote many of the most important songs in that catalogue including Umbrella (Rihanna), Single Ladies (Put A Ring On It) (Beyoncé), Baby (Justin Bieber), Me Against The Music (Britney Spears & Madonna) and Touch My Body (Mariah Carey).

In addition to songs co-written with The-Dream the catalogue includes numerous other songs with Katy Perry from one of her most successful albums, Teenage Dream, and other songs with Christina Aguilera, Rick Ross, Whitney Houston, Jennifer Lopez, Nicole Scherzinger and Ciara.

Merck Mercuriadis, Founder of The Family (Music) Limited and Hipgnosis Songs Fund Limited, said:

"This is a tremendously important acquisition for Hipgnosis and me. In addition to giving us greater ownership of multiple Grammy Award winning Number 1 songs like Rihanna's Umbrella and Beyoncé's Single Ladies (Put A Ring On It) we are also reuniting the catalogues of Tricky Stewart and The-Dream who are arguably the finest song-writing duo of their time. These songs are big pop successes but it's sophisticated music of the highest order and these songs are already classics not to mention by the culturally most important artists of their time. Tricky is a tremendous individual, writer, producer and musician whose work backs up all of the tremendous accolades and success. This is family!"

Tricky Stewart, said:

"There is a right way and wrong way to do everything. The sale of my catalog to Hipgnosis is right for me. Selling to a friend who is fuelled by purpose, motivated to do great things, with a disruptive spirit and vigour caught my attention, and ultimately led to me completing this transaction. I'm truly blessed to have these kinds of options in my life and for that WE GIVE GOD THE GLORY. Over the next 5 years I will be creating another catalog filled with Hits and culture, and I'll do it all over again! I love music and music loves me."

Mark E. Stewart - Tricky Stewart's Manager - commented:

"When Trick and I discussed selling his catalog, Merck was the first person I heard from. Merck and Hipgnosis are definitely buyers that have respect for the songs and for the writers who created them, and even the stories behind the creations. Merck is a music man first,but happens to make deals with the utmost respect for the creator.

Closing a major transaction like this with a man like Merck made perfect sense because of our long lasting working relationship. I congratulate him and Hipgnosis on another great acquisition."

For further information, please contact:

The Family (Music) Limited

Merck Mercuriadis

 

Tel: +44 (0)1481 742742

N+1 Singer

James Maxwell / James Moat (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales)

 

Tel: +44 (0)20 7496 3000

The Outside Organisation

Alan Edwards / Nick Caley

Tel: +44 (0)7711 081 843

 

NOTES TO EDITORS

About Hipgnosis Songs Fund Limited

(www.hipgnosissongs.com)

Hipgnosis, which was founded by Merck Mercuriadis, is a Guernsey registered investment company established to offer investors a pure-play exposure to songs and associated musical intellectual property rights. In its Initial Public Offering on the Specialist Fund Segment of the London Stock Exchange's main market on 11 July 2018, the Company raised approximately £200m gross equity capital.

About The Family (Music) Limited

The Company's Investment Adviser is The Family (Music) Limited, which was founded by Merck Mercuriadis, former manager of globally successful recording artists, such as Elton John, Guns N' Roses, Morrissey, Iron Maiden and Beyoncé, and hit songwriters such as Diane Warren, Justin Tranter and The-Dream, and former CEO of The Sanctuary Group plc.  The Investment Adviser has assembled an Advisory Board of highly successful music industry experts which include award winning members of the artist, songwriter, publishing, legal, financial, recorded music and music management communities, all with in-depth knowledge of music publishing. Members of The Family (Music) Limited Advisory Board include Nile Rodgers, The-Dream, Bill Leibowitz, Ian Montone, and Jason Flom.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
ACQTRBLTMBIBMTP
Date   Source Headline
15th Apr 20247:00 amRNSChange to Director roles and responsibilities
28th Mar 20249:02 amRNSFinal Due Diligence Findings
18th Mar 20247:00 amRNSAmendment to Operative Net Asset Value
4th Mar 20249:27 amRNSUpdate on Due Diligence, Valuation and NAV
4th Mar 20247:00 amRNSUpdate on Due Diligence, Valuation and NAV
26th Feb 20247:00 amRNSLitigation update
19th Feb 20247:00 amRNSLitigation Update
7th Feb 202412:35 pmRNSResult of Extraordinary General Meeting (“EGM”)
5th Feb 20247:00 amRNSLitigation Update
23rd Jan 20247:00 amRNSPublication of Circular/Update to Strategic Review
18th Jan 20247:00 amRNSProposed Change to Articles of the Company
11th Jan 20247:00 amRNSDirectorate Change
4th Jan 20243:26 pmRNSHolding(s) in Company
21st Dec 20237:00 amRNSInterim results to 30 September 2023
20th Dec 20237:00 amRNSChange of Auditor
19th Dec 20237:00 amRNSDelay to publication of interim results
15th Dec 20237:00 amRNSDirectorate Change
11th Dec 20237:00 amRNSAsset sale, adviser appointment, notice of results
28th Nov 202312:52 pmRNSHolding(s) in Company
23rd Nov 20237:00 amRNSStrategic Review and Company Update
20th Nov 20237:00 amRNSDirector/PDMR Shareholding
7th Nov 20237:00 amRNSDirectorate Changes
6th Nov 20237:00 amRNSUpdate on dividend intentions
26th Oct 202311:20 amRNSResult of AGM and EGM
25th Oct 20234:00 pmRNSDirectorate Changes, withdrawal of AGM Resolutions
24th Oct 20237:00 amRNSConclusion of Go-Shop process
19th Oct 20237:00 amRNSInitiation of Strategic Review, update on RCF
17th Oct 202312:22 pmRNSHolding(s) in Company
17th Oct 202312:21 pmRNSHolding(s) in Company
17th Oct 202312:18 pmRNSHolding(s) in Company
16th Oct 20236:17 pmRNSUpdate on CRB III and dividend payment
16th Oct 20237:13 amRNSUpdate on CRB III impact and dividend payment
28th Sep 202311:07 amRNSPublication of Circular and Notice of AGM & EGM
25th Sep 20232:41 pmRNSHolding(s) in Company
22nd Sep 202310:49 amRNSHolding(s) in Company
21st Sep 20237:00 amRNSDividend Declaration
20th Sep 20237:00 amRNSHolding(s) in Company
14th Sep 20237:00 amRNSAsset sales to fund buy backs and reduce debt
14th Aug 202312:29 pmRNSDirector/PDMR Shareholding
13th Jul 20237:00 amRNSAnnual Financial Report
10th Jul 20237:00 amRNSDirectorate Change and Notice of Results
23rd Jun 202312:02 pmRNSDividend Declaration
16th May 20237:00 amRNSCorrection of Director/PDMR Shareholding
15th May 20234:32 pmRNSDirector/PDMR Shareholding
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.